#100000
I'm interested in <a href=" https://www.wesearchtogether.org/about.php#opposite ">diflucan 150 mg tablet</a> Immunocore's technology relies on a new type of medicines it calls "ImmTACs." These drugs exploit the power of T cell receptors â a part of the immune system - to recognize changes that occur inside cells during cancer or viral infection. ImmTACs then activate the immune system to kill targeted cells.
